Shore Capital reaffirmed their buy rating on shares of Marston's (LON:MARS – Get Rating) in a research report released on Wednesday morning, Marketbeat.com reports.
A number of other equities research analysts have also recently issued reports on MARS. Peel Hunt reissued a buy rating and issued a GBX 120 ($1.45) target price on shares of Marston's in a research report on Tuesday, April 12th. Deutsche Bank Aktiengesellschaft raised shares of Marston's to a hold rating and reduced their target price for the company from GBX 65 ($0.78) to GBX 60 ($0.72) in a research report on Wednesday, May 25th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Marston's currently has an average rating of Moderate Buy and an average price target of GBX 93 ($1.12).
Get Marston's alerts:Marston's Trading Down 0.1 %
Shares of Marston's stock opened at GBX 47.74 ($0.58) on Wednesday. The firm has a 50-day moving average of GBX 52.11 and a 200-day moving average of GBX 68.14. The stock has a market cap of £302.75 million and a PE ratio of -17.05. Marston's has a 52-week low of GBX 43 ($0.52) and a 52-week high of GBX 88.45 ($1.07). The company has a debt-to-equity ratio of 395.24, a quick ratio of 0.25 and a current ratio of 0.33.
Insider Buying and Selling
In other news, insider William Rucker acquired 200,000 shares of the business's stock in a transaction that occurred on Thursday, May 19th. The stock was acquired at an average price of GBX 57 ($0.69) per share, with a total value of £114,000 ($137,349.40).Marston's Company Profile
(Get Rating)
Marston's PLC operates managed, franchised, tenanted, and leased pubs, bars, restaurants, and accommodations in the United Kingdom and internationally. The company operates through approximately 1,500 bars and pubs; and approximately 1,836 rooms. It is also involved in the property management; telecommunications; and insurance businesses.
Featured Stories
- MarketBeat: Week in Review 7/25 – 7/29
- Procter's Earnings Start To Show Weakness In Q4
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for Marston's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marston's and related companies with MarketBeat.com's FREE daily email newsletter.